Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. SMLR
stocks logo

SMLR

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
AI Stock Picker
AI Stock Picker

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q3
7.87M
-41.79%
-0.145
-124.45%
Estimates Revision
The market is revising Downward the revenue expectations for Semler Scientific, Inc. (SMLR) for FY2025, with the revenue forecasts being adjusted by -8.01% over the past three months. During the same period, the stock price has changed by -36.70%.
Revenue Estimates for FY2025
Revise Downward
down Image
-8.01%
In Past 3 Month
EPS Estimates for FY2025
Revise Upward
up Image
+3.28%
In Past 3 Month
Stock Price
Go Down
down Image
-36.70%
In Past 3 Month
Wall Street analysts forecast SMLR stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for SMLR is 68.50 USD with a low forecast of 51.00 USD and a high forecast of 86.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
2 Analyst Rating
Wall Street analysts forecast SMLR stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for SMLR is 68.50 USD with a low forecast of 51.00 USD and a high forecast of 86.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
2 Buy
0 Hold
0 Sell
Moderate Buy
Current: 17.970
sliders
Low
51.00
Averages
68.50
High
86.00
Current: 17.970
sliders
Low
51.00
Averages
68.50
High
86.00
Maxim
Matthew Galinko
Buy
downgrade
$95 -> $80
2025-09-19
Reason
Maxim
Matthew Galinko
Price Target
$95 -> $80
2025-09-19
downgrade
Buy
Reason
Maxim analyst Matthew Galinko lowered the firm's price target on Semler Scientific to $80 from $95 and keeps a Buy rating on the shares. The firm is cutting its estimates for revenue in 2025-27 due to the management's guidance and its own estimates, the analyst tells investors in a research note. Maxim also cites Semler having entered into a settlement agreement with the Civil Fraud Section of the Department of Justice, the Department of Health and Human Services, and certain relators to settle all potential claims related to alleged civil violations of the False Claims Act, the firm added.
Cantor Fitzgerald
Brett Knoblauch
initiated
$61
2025-07-28
Reason
Cantor Fitzgerald
Brett Knoblauch
Price Target
$61
2025-07-28
initiated
Reason
Cantor Fitzgerald analyst Brett Knoblauch initiated coverage of Semler Scientific with an Overweight rating and $61 price target.
Maxim
NULL -> Buy
initiated
$95
2025-07-09
Reason
Maxim
Price Target
$95
2025-07-09
initiated
NULL -> Buy
Reason
Maxim initiated coverage of Semler Scientific with a Buy rating and $95 price target.
Lake Street
Brooks O'Neil
Strong Buy
Maintains
$40 → $71
2025-01-24
Reason
Lake Street
Brooks O'Neil
Price Target
$40 → $71
2025-01-24
Maintains
Strong Buy
Reason
See All Ratings

Valuation Metrics

The current forward P/E ratio for Semler Scientific Inc (SMLR.O) is -15.76, compared to its 5-year average forward P/E of 21.59. For a more detailed relative valuation and DCF analysis to assess Semler Scientific Inc 's fair value, click here.
  • Forward PE
  • Forward EV/EBITDA
  • Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
21.59
Current PE
-15.76
Overvalued PE
52.58
Undervalued PE
-9.41

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
13.90
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
30.10
Undervalued EV/EBITDA
-2.30

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
7.30
Current PS
0.00
Overvalued PS
11.94
Undervalued PS
2.67
Financial AI Agent
Financial AI Agent

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %
N/A
ROIC

Trading Trends

  • Insider
  • Hedge Fund
  • Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Intellectia AI SwingMax
Intellectia AI SwingMax

SMLR News & Events

Events Timeline

(ET)
2025-12-10
12:50:00
Wall Street Remains Bullish on Strategy Despite Stock Price Drop
select
2025-10-20 (ET)
2025-10-20
08:11:01
ProCap BTC names Renae Cormier as Chief Financial Officer
select
2025-09-22 (ET)
2025-09-22
08:21:32
Strive and Semler Scientific Reveal All-Stock Merger Involving Bitcoin Treasury
select
Sign Up For More Events
Sign Up For More Events

News

[object Object]
Preview
8.5
06:41 AMPRnewswire
Semler Scientific to be Sold to Strive, Shareholders to Receive 21.05 Shares Each
  • Transaction Investigation: Former Louisiana Attorney General Charles C. Foti and Kahn Swick & Foti are investigating the proposed sale of Semler Scientific to Strive, Inc., aiming to assess the adequacy of the transaction terms.
  • Shareholder Rights Concern: Under the proposed terms, Semler shareholders will receive 21.05 shares of Strive for each share they own, raising questions about the company's valuation that could impact shareholder decisions.
  • Legal Consultation Opportunity: KSF encourages shareholders who believe the transaction undervalues the company to reach out for legal consultation, highlighting a commitment to protecting shareholder rights.
  • Potential Market Impact: This investigation may lead to fluctuations in Semler's stock price, particularly as shareholder reactions to the transaction terms could influence future investor confidence.
[object Object]
Preview
8.5
12-10Globenewswire
Wohl & Fruchter Investigates Semler-Strive Merger Fairness Amid Fixed Exchange Ratio Concerns
  • Merger Fairness Investigation: Wohl & Fruchter LLP is investigating the proposed merger between Semler Scientific and Strive Asset Management due to concerns over the fixed exchange ratio of 21.05 shares of Strive for each Semler share, which may adversely affect shareholder interests.
  • Stock Price Decline Impact: Since the merger announcement on September 22, 2025, Strive's stock price has plummeted, causing Semler's stock to drop from $32.06 to $19.77, significantly diminishing the merger's appeal and potentially leading to shareholder opposition.
  • Legal Consultation Opportunity: Wohl & Fruchter LLP offers free legal consultations for Semler shareholders to discuss the fairness of the merger and their legal rights, demonstrating a commitment to protecting shareholder interests.
  • Investor Rights Protection: The firm has over a decade of experience representing investors in litigation related to fraud and corporate misconduct, recovering hundreds of millions in damages, highlighting its expertise in safeguarding investor rights.
[object Object]
Preview
8.5
12-05Globenewswire
Gulf Island Fabrication Shareholders to Receive $12 Cash per Share in IES Holdings Deal
  • Shareholder Returns: Gulf Island Fabrication, Inc. is set to be sold to IES Holdings, Inc. for $12 cash per share, which is expected to provide significant cash returns to shareholders, enhancing the investment appeal of the company.
  • Voting Arrangement: The shareholder vote is scheduled for January 13, 2026, allowing ample time for shareholders to evaluate the terms of the transaction and make informed decisions.
  • Legal Support: Monteverde & Associates PC, acting as the representative law firm, has recovered millions for shareholders, demonstrating its strong capabilities and reputation in securities class action litigation.
  • Market Reaction: The announcement of this transaction may influence Gulf Island's stock price movements, prompting investors to monitor market reactions and the potential implications for the company's future development.
Sign Up For More News

People Also Watch

FAQ

arrow icon

What is Semler Scientific Inc (SMLR) stock price today?

The current price of SMLR is 17.97 USD — it has decreased -6.5 % in the last trading day.

arrow icon

What is Semler Scientific Inc (SMLR)'s business?

Semler Scientific, Inc. is engaged in developing and marketing technology products and services to healthcare providers to combat chronic diseases. The Company's flagship product, QuantaFlo, which is patented and cleared by the United States Food and Drug Administration (FDA), is a rapid point-of-care test that measures arterial blood flow in the extremities. The QuantaFlo test aids in the diagnosis of cardiovascular diseases, such as peripheral arterial disease (PAD), and the Company is seeking a new 510(k) clearance for expanded-indications. QuantaFlo is used by healthcare providers to evaluate their patient's risk of mortality and major adverse cardiovascular events (MACE). QuantaFlo features a sensor clamp that is placed on the toe or finger. A blood flow waveform is instantaneously constructed by its software algorithm. The Company delivers QuantaFlo directly to its customers. The Company also invests in bitcoin and has adopted Bitcoin as its primary treasury asset.

arrow icon

What is the price predicton of SMLR Stock?

Wall Street analysts forecast SMLR stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for SMLR is 68.50 USD with a low forecast of 51.00 USD and a high forecast of 86.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is Semler Scientific Inc (SMLR)'s revenue for the last quarter?

Semler Scientific Inc revenue for the last quarter amounts to 7.49M USD, decreased -44.56 % YoY.

arrow icon

What is Semler Scientific Inc (SMLR)'s earnings per share (EPS) for the last quarter?

Semler Scientific Inc. EPS for the last quarter amounts to 1.07 USD, increased 48.61 % YoY.

arrow icon

What changes have occurred in the market's expectations for Semler Scientific Inc (SMLR)'s fundamentals?

The market is revising Downward the revenue expectations for Semler Scientific, Inc. (SMLR) for FY2025, with the revenue forecasts being adjusted by -8.01% over the past three months. During the same period, the stock price has changed by -36.70%.
arrow icon

How many employees does Semler Scientific Inc (SMLR). have?

Semler Scientific Inc (SMLR) has 79 emplpoyees as of December 13 2025.

arrow icon

What is Semler Scientific Inc (SMLR) market cap?

Today SMLR has the market capitalization of 274.67M USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free